Source 1review2018Stem Cells International
Toolkit/epigenetic element screening
epigenetic element screening
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Epigenetic element screening is described in a 2018 review as a CRISPR/Cas9-based epigenetic technique. The supplied evidence establishes only that it belongs to the set of CRISPR/Cas9-enabled approaches used in epigenetics, without further methodological detail.
Usefulness & Problems
Why this is useful
Based on the review context, this approach is useful as part of the expanded experimental repertoire that CRISPR/Cas9 has brought to epigenetics. The available evidence does not specify the assay format, readout, or biological endpoints measured by the screening strategy.
Problem solved
The evidence supports that this method addresses an epigenetics-related screening problem within the broader CRISPR/Cas9 toolkit. However, the specific problem solved, such as identifying regulatory DNA elements or mapping chromatin function, is not stated in the supplied sources.
Problem links
Need better screening or enrichment leverage
DerivedEpigenetic element screening is described in a 2018 review as one of several novel epigenetic techniques enabled by the CRISPR/Cas9 system. The supplied evidence establishes only that it is a CRISPR/Cas9-based epigenetic screening approach, without further methodological detail.
Need conditional recombination or state switching
DerivedEpigenetic element screening is described in a 2018 review as one of several novel epigenetic techniques enabled by the CRISPR/Cas9 system. The supplied evidence establishes only that it is a CRISPR/Cas9-based epigenetic screening approach, without further methodological detail.
Need controllable genome or transcript editing
DerivedEpigenetic element screening is described in a 2018 review as one of several novel epigenetic techniques enabled by the CRISPR/Cas9 system. The supplied evidence establishes only that it is a CRISPR/Cas9-based epigenetic screening approach, without further methodological detail.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Target processes
editingrecombinationselectionImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The only implementation detail supported by the evidence is that the method is CRISPR/Cas9-based. No information is provided on guide RNA design, nuclease activity, effector domains, delivery system, cell type, or selection/readout strategy.
The evidence is limited to review-level mention and does not define construct design, Cas9 variant usage, screening scale, or assay outputs. There is no primary experimental validation, organismal context, or benchmark information in the supplied material.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The emergence of CRISPR/Cas9 technology has provided new routes into the epigenetics field.
In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Approval Evidence
1 source1 linked approval claimfirst-pass slug epigenetic-element-screening
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including ... epigenetic element screening.
Source:
review scopesupports
The review covers CRISPR/Cas9-based epigenetic techniques including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.
Source:
Comparisons
Source-backed strengths
A stated strength is its inclusion among novel epigenetic techniques enabled by CRISPR/Cas9, indicating conceptual relevance to modern epigenetics workflows. No direct performance data, validation results, or comparative advantages are provided in the supplied evidence.
Compared with chromatin in vivo imaging
epigenetic element screening and chromatin in vivo imaging address a similar problem space because they share editing, recombination, selection.
Shared frame: same top-level item type; shared target processes: editing, recombination, selection
Compared with high throughput screening
epigenetic element screening and high throughput screening address a similar problem space because they share editing, recombination, selection.
Shared frame: same top-level item type; shared target processes: editing, recombination, selection
Compared with whole genome screening of gene knockout mutants
epigenetic element screening and whole genome screening of gene knockout mutants address a similar problem space because they share editing, recombination, selection.
Shared frame: same top-level item type; shared target processes: editing, recombination, selection
Ranked Citations
- 1.